Medical Care Cost of Oropharyngeal Cancer among Texas Patients.

about

Medical Care Cost of Oropharyngeal Cancer among Texas Patients.

Item

http://www.wikidata.org/entity/Q38609505

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Medical Care Cost of Oropharyngeal Cancer among Texas Patients.

@en

type

Item

label

Medical Care Cost of Oropharyngeal Cancer among Texas Patients.

@en

prefLabel

Medical Care Cost of Oropharyngeal Cancer among Texas Patients.

@en

P1476

Medical Care Cost of Oropharyngeal Cancer among Texas Patients

@en

P2093

Chi-Fang Wu

http://www.w3.org/2001/XMLSchema#string

David R Lairson

http://www.w3.org/2001/XMLSchema#string

Erich M Sturgis

http://www.w3.org/2001/XMLSchema#string

Samantha Tam

http://www.w3.org/2001/XMLSchema#string

Wenyaw Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment

Matching methods for causal inference: A review and a look forward

The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data.

Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.

HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.

An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair.

The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, Medicare, and Medicaid.

The economic burden of noncervical human papillomavirus disease in the United States.

US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines

P304

1443-1449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-17-0220

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kristina R. Dahlstrom

P577

2017-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28838945

http://www.w3.org/2001/XMLSchema#string

P932

5903433

http://www.w3.org/2001/XMLSchema#string